Flector and Mucosal inflammation - a phase IV clinical study of FDA data

Summary:

Mucosal inflammation is reported as a side effect among people who take Flector (diclofenac epolamine), especially for people who are female, 50-59 old, also take Morphine, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Mucosal inflammation when taking Flector. It is created by eHealthMe based on reports of 5,075 people who have side effects when taking Flector from the FDA, and is updated regularly.

What is Flector?

Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.

What is Mucosal inflammation?

Mucosal inflammation (infection of mucous membrane) is found to be associated with 1,191 drugs and 1,241 conditions by eHealthMe. Check the latest studies of Mucosal inflammation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,075 people reported to have side effects when taking Flector.
Among them, 13 people (0.26%) have Mucosal inflammation.

Could Flector cause Mucosal inflammation?

Among these 13 people:

What is the gender of people who have Mucosal inflammation when taking Flector? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Mucosal inflammation when taking Flector? *

What are other drugs people take besides Flector? *

What are other side effects people have besides Mucosal inflammation? *

Nausea (feeling of having an urge to vomit): 10 people, 76.92%
Fever: 9 people, 69.23%
Dyspnea (difficult or laboured breathing): 8 people, 61.54%
Drowsiness: 8 people, 61.54%
Anaemia (lack of blood): 8 people, 61.54%
Weakness: 8 people, 61.54%
Chest Pain: 8 people, 61.54%
Thrombocytopenia (decrease of platelets in blood): 8 people, 61.54%
Hyperthyroidism (over activity of the thyroid gland): 7 people, 53.85%
Lung Disorder (lung disease): 7 people, 53.85%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 53.85%
Tumor: 5 people, 38.46%
Tumor Pain: 1 person, 7.69%
Trismus (reduced opening of the jaws): 1 person, 7.69%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Flector and have Mucosal inflammation?

- Check whether Mucosal inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flector:

Flector (5,112 reports)

Browse all side effects of Flector:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mucosal inflammation:

Mucosal inflammation (1,191 drugs)

Browse all the conditions that are associated with Mucosal inflammation:

Mucosal inflammation (1,241 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac epolamine (the active ingredients of Flector) and Flector (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.